Manifold Biotechnologies, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Manifold Biotechnologies, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2024).
SEC Form D · Dec 2024
The industry group it chose in its notices: Biotechnology.
SEC Form D · Dec 2024
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Manifold Biotechnologies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Gleb Kuznetsov | Executive officer | Dec 2024 |
| Pierce Ogden | Executive officer | Dec 2024 |
| Gleb Kuznetsov | Director | Dec 2024 |
| Jeff Huber | Director | Dec 2024 |
| Jory Bell | Director | Dec 2024 |
| Pierce Ogden | Director | Dec 2024 |
| Steven Holtzman | Director | Dec 2024 |
| Steven J. Kafka | Director | Dec 2024 |
| Gleb Kuznetsov | Promoter | Jun 2022 |
| Pierce Ogden | Promoter | Jun 2022 |